Fundraising Foxatai Life Sciences — Full Portfolio
4 tracked investments · listed companies and verified rows first
Cambrian Bio is a clinical-stage drug development company creating precision therapeutics that target metabolic pathways which decline with age, such as AMPK and mTOR.
BiotechHealthtechLongevityNew York, US
James Peyer(CEO, Founder, Board Director)inMark Nuttall(Chief Business Officer)inRuth Thieroff-Ekerdt(Chief Medical Officer)inBill DeVaul(Chief Legal Officer)in
BoardMaryanna Saenko(Director)in
Board seatChristian Angermayer· per SEC Form D · $37.6M raise · filed Jan 2025
Co-investorsAlumni VenturesCatalio Capital Management, LPDEFTA PartnersFJ LabsFuture VenturesKhosla Ventures+5 more
Cleveland Clinic is a multi-specialty healthcare organization and hospital system founded in 1921, ranked among the top hospitals in the country.
Digital HealthHealthtechMedical DevicesCleveland, US
Tomislav Mihaljevic, M.D.in
Co-investorsAtaiBeckley
Recognify is a biotech company developing therapeutic and diagnostic products for CNS disease, oncology, and infectious disease.
BiotechDigital HealthMental Health
Gary Walker(Founder, VP Clinical Development)inThomas C. Südhof(Founder, Chairman of SAB)Angela Macfarlane(Founder, Board Member, Business Advisor)Matt Pando(Founder, CEO/President)in
Co-investorsCatalio Capital Management, LP
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Mayo Clinic
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.